Biodesix, Inc. vs Neuronetics, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Biodesix, Inc. is the larger company by market value: $265 M against $162 M for Neuronetics, Inc., 1.6 times as much (market caps of Oct 23, 2026).
- Neuronetics, Inc. had more revenue: $149 M against $88 M for Biodesix, Inc., both in the year to December 2025.
- Both made a net loss: $35 M for Biodesix, Inc. and $39 M for Neuronetics, Inc.
- Neuronetics, Inc. keeps more of each dollar of sales: a net margin of -26.1% against -39.8% for Biodesix, Inc.
- Neuronetics, Inc.'s revenue grew faster in its latest fiscal year: +99.2% against +24.1% for Biodesix, Inc.
- Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2021: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Biodesix, Inc. BDSX · #15,219 in the world | Neuronetics, Inc. STIM · #17,013 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | — | 2003 |
| Size | ||
| Market cap | $265 M | $162 M |
| Revenue | $89 M | $149 M |
| Net income | $-35 M▲ best | $-39 M |
| Valuation | ||
| Price to sales | 2.5× | 1.0× |
| Price to book | — | 7.2× |
| Free cash flow yield | -8.9%▲ best | -13.1% |
| Profitability | ||
| Gross margin | — | 48.5% |
| Operating margin | -31.5% | -21.1%▲ best |
| Net margin | -39.8% | -26.1%▲ best |
| Return on equity | — | -155.7% |
| Growth | ||
| Revenue growth | 24.1% | 99.2%▲ best |
| Revenue growth, 3 years a year | 32.3%▲ best | 31.8% |
| Financial strength | ||
| Debt to equity | — | 2.9× |
| Interest cover | -3.6×▲ best | -4.1× |
| Cash | ||
| Free cash flow margin | -26.6% | -14.2%▲ best |
| Strength scores | ||
| Piotroski F-score | — | 4 of 9 |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Biodesix, Inc. or Neuronetics, Inc.?
Biodesix, Inc. is the larger company by market value: $265 M against $162 M for Neuronetics, Inc., 1.6 times as much (market caps of Oct 23, 2026).
Which makes more money, Biodesix, Inc. or Neuronetics, Inc.?
Neuronetics, Inc. had more revenue: $149 M against $88 M for Biodesix, Inc., both in the year to December 2025. Both made a net loss: $35 M for Biodesix, Inc. and $39 M for Neuronetics, Inc.
Which is more profitable, Biodesix, Inc. or Neuronetics, Inc.?
Neuronetics, Inc. keeps more of each dollar of sales: a net margin of -26.1% against -39.8% for Biodesix, Inc.
Which is growing faster, Biodesix, Inc. or Neuronetics, Inc.?
Neuronetics, Inc.'s revenue grew faster in its latest fiscal year: +99.2% against +24.1% for Biodesix, Inc.
Which is financially stronger, Biodesix, Inc. or Neuronetics, Inc.?
Both are in the distress zone of the Altman Z-score.